Table 1 Primer sequences for human SLC transporters

From: Expression of human solute carrier family transporters in skin: possible contributor to drug-induced skin disorders

Subtypes

Forward primers (5′to 3′)

Reverse primers (5′to 3′)

SLC10A1

CTGAGCGTCATCCTGGTGTT

TTCATGTCCCCCTTCATGGC

SLC10A2

TGGCCTTGGTGATGTTCTCC

TGTCGCCATCGACCCAATAG

CDH17

TGGATATGGCCAAGAGGGGA

ATAGGGACTGGACCCTCCAC

SLC15A1

CAAGTGCATCGGTTTTGCCA

CCCGGACATAGTTGTTGCCT

SLC15A2

TGATCAAGTCCTTGGGTGCC

CCCTGCATTGATGGACAGGT

SLC16A1

CACCAGCGAAGTGTCATGGA

TCAAGTTGAAGGCAAGCCCA

SLC16A4

GGGACTTCTACCCGGTTTGG

CATGTGCCTCTGGACCATGT

SLC22A1

TCTGTGCTCTATCAGGGGCT

TGATTCCCATTCGGCCAACA

SLC22A2

GTTGGGCGGAGATATCGGAG

AAGGGAGGCGGGTAGAGATT

SLC22A3

TCCCCAACTGGCAAGGAATC

ATACACCACTGCGCTTGTGA

SLC22A4

GTTCAGCCAGGACGTCTACC

AGCCATGGTTGCGAAGAGAA

SLC22A5

TGGCACTCTGGTGGTTCATC

CTGGGACTTCAACCATCGCT

SLC22A6

TTCGGCTACCTTGCAGACAG

GAATGGGCATCCACTCCACA

SLC22A7

TGCAACTGAGTGGGATCTGG

AGCACCAGGGTACTCACGTA

SLC22A8

ACTCGGGTACTGCTACACCT

CAGGTCACTTGCGGTGTACT

SLC22A9

AGGTTCGTGCTCAGATGGTG

CCATGGCCTGGAATCTGTGT

SLC22A11

TTATCTGGGGCCTCCTCTCC

GTGGTCCACTCCACCATCAG

SLC28A3

GGGGAATCGGGCTACAGTTT

CAGCAGTGGAGACTCCGTTT

SLCO1A2

ACCAACGCAGGATCCATCAG

AAAGCCAAACCACCATGCAC

SLCO1B1

ACTGTCTTTGCATGTGCTGG

GGCAATTCCAACGGTGTTCA

SLCO1B3

GCAGCCCTGTCATTCAGCTA

CAGTTCCCATAAGGAGACAACCA

SLCO1C1

ACTCCCATTCAGCCTTTGGG

CAGAAAGGCACAGCTGCAAG

SLCO2B1

TGGGCACAGAAAACACACCT

CGGCTGCCAAAATAGCTCAC

SLCO3A1

CTCCTACATCGACGACCACG

TCTCTTTCGGAGAGCATGGC

SLCO4A1

GCGTCACCTACCTGGATGAG

TAACCAAGGATGGGAACGGC

SLCO4C1

TTCTGTGCCCACACACAAGT

CCAATCCACCAAGCTCCCAA

PCFT

GCTGATAGCCATGACTCTCT

CAGAACCATAGCCGATTAGT

RFC

GAGCAGCATCTGGCTGTGCT

GCACGTCCGAGACAATGAAAGT

Back to article page